Financhill
Sell
4

XCH Quote, Financials, Valuation and Earnings

Last price:
$1.92
Seasonality move :
--
Day range:
$1.82 - $2.20
52-week range:
$1.36 - $30.47
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.18x
P/B ratio:
--
Volume:
1.2M
Avg. volume:
703.2K
1-year change:
--
Market cap:
$124.6M
Revenue:
$38.5M
EPS (TTM):
-$0.20
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- $13.2M $29.4M $38.5M
Revenue Growth (YoY) -- -- -- 123.65% 30.89%
 
Cost of Revenues -- -- $8.5M $18.7M $20.9M
Gross Profit -- -- $4.6M $10.7M $17.6M
Gross Profit Margin -- -- 35.17% 36.38% 45.63%
 
R&D Expenses -- -- $1.7M $2.8M $4.1M
Selling, General & Admin -- -- $4.4M $6.3M $20.3M
Other Inc / (Exp) -- -- -$454.4K -$186.6K -$1.2M
Operating Expenses -- -- $6.1M $9.1M $24M
Operating Income -- -- -$1.5M $1.7M -$6.4M
 
Net Interest Expenses -- -- $125.6K -- $522.7K
EBT. Incl. Unusual Items -- -- -$2.1M $1.6M -$8.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- $1.3K -$11.6K --
Net Income to Company -- -- -$2.1M $1.6M -$8.1M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -$2.1M $1.6M -$8.1M
 
Basic EPS (Cont. Ops) -- -- -$0.09 $0.00 -$0.18
Diluted EPS (Cont. Ops) -- -- -$0.09 $0.00 -$0.18
Weighted Average Basic Share -- -- $59.3M $59.3M $59.3M
Weighted Average Diluted Share -- -- $59.3M $59.3M $59.3M
 
EBITDA -- -- -$1.5M $1.8M -$7.7M
EBIT -- -- -$1.7M $1.7M -$7.9M
 
Revenue (Reported) -- -- $13.2M $29.4M $38.5M
Operating Income (Reported) -- -- -$1.5M $1.7M -$6.4M
Operating Income (Adjusted) -- -- -$1.7M $1.7M -$7.9M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue -- -- -- $12.2M $9M
Revenue Growth (YoY) -- -- -- -- -26.28%
 
Cost of Revenues -- -- -- $6.7M $4.8M
Gross Profit -- -- -- $5.5M $4.2M
Gross Profit Margin -- -- -- 44.71% 46.15%
 
R&D Expenses -- -- -- $992.1K $1.2M
Selling, General & Admin -- -- -- $2.4M $3.9M
Other Inc / (Exp) -- -- -- -$16.4K -$9.5K
Operating Expenses -- -- -- $3.4M $5.1M
Operating Income -- -- -- $2.1M -$923K
 
Net Interest Expenses -- -- -- $6K $18.7K
EBT. Incl. Unusual Items -- -- -- $2M -$951.2K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- $1.6M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $2M -$951.2K
 
Basic EPS (Cont. Ops) -- -- -- $0.01 -$0.02
Diluted EPS (Cont. Ops) -- -- -- $0.01 -$0.02
Weighted Average Basic Share -- -- -- $59.3M $59.3M
Weighted Average Diluted Share -- -- -- $59.3M $59.3M
 
EBITDA -- -- -- $2.1M -$879.8K
EBIT -- -- -- $2.1M -$879.8K
 
Revenue (Reported) -- -- -- $12.2M $9M
Operating Income (Reported) -- -- -- $2.1M -$923K
Operating Income (Adjusted) -- -- -- $2.1M -$879.8K
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue -- -- -- $40.1M $39.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $23.8M $20.2M
Gross Profit -- -- -- $16.3M $18.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $3.2M $4.5M
Selling, General & Admin -- -- -- $8.3M $23.4M
Other Inc / (Exp) -- -- -- $126.1K -$1.4M
Operating Expenses -- -- -- $11.5M $27.4M
Operating Income -- -- -- $4.8M -$8.6M
 
Net Interest Expenses -- -- -- -- $535K
EBT. Incl. Unusual Items -- -- -- $5M -$10.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $300 $11.3K
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $5M -$10.5M
 
Basic EPS (Cont. Ops) -- -- -- $0.02 -$0.20
Diluted EPS (Cont. Ops) -- -- -- $0.02 -$0.20
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- $5.1M -$10.3M
EBIT -- -- -- $5.1M -$10.3M
 
Revenue (Reported) -- -- -- $40.1M $39.1M
Operating Income (Reported) -- -- -- $4.8M -$8.6M
Operating Income (Adjusted) -- -- -- $5.1M -$10.3M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Revenue -- -- -- $19.6M $20.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $11M $10.3M
Gross Profit -- -- -- $8.6M $9.8M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- $1.7M $2.2M
Selling, General & Admin -- -- -- $4.7M $7.6M
Other Inc / (Exp) -- -- -- $135.2K -$239.8K
Operating Expenses -- -- -- $6.4M $9.7M
Operating Income -- -- -- $2.1M $67.3K
 
Net Interest Expenses -- -- -- $21.7K $34.2K
EBT. Incl. Unusual Items -- -- -- $2.2M -$206.9K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $11.3K
Net Income to Company -- -- -- $1.6M --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- $2.2M -$218.2K
 
Basic EPS (Cont. Ops) -- -- -- $0.01 -$0.02
Diluted EPS (Cont. Ops) -- -- -- $0.01 -$0.02
Weighted Average Basic Share -- -- -- $118.6M $118.6M
Weighted Average Diluted Share -- -- -- $118.6M $118.6M
 
EBITDA -- -- -- $2.3M -$91.8K
EBIT -- -- -- $2.3M -$91.8K
 
Revenue (Reported) -- -- -- $19.6M $20.1M
Operating Income (Reported) -- -- -- $2.1M $67.3K
Operating Income (Adjusted) -- -- -- $2.3M -$91.8K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- $4.8M $8.3M $15.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- $4.3M $7.6M $12.5M
Inventory -- -- $3.2M $6.2M $6.7M
Prepaid Expenses -- -- $845.4K $581.4K $363.6K
Other Current Assets -- -- $89.9K $194.3K $198.2K
Total Current Assets -- -- $14M $28.2M $39.7M
 
Property Plant And Equipment -- -- $369.5K $790.5K $1.1M
Long-Term Investments -- -- -- $107.7K $105.9K
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- $19.2M $29.1M $41M
 
Accounts Payable -- -- $2.9M $6.6M $5.8M
Accrued Expenses -- -- $1.8M $3.1M $4.1M
Current Portion Of Long-Term Debt -- -- -- -- $12.5M
Current Portion Of Capital Lease Obligations -- -- $86.6K $236.4K $294K
Other Current Liabilities -- -- $560.4K $782.7K $513.9K
Total Current Liabilities -- -- $9.1M $18M $30.7M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- $49.9M $57.2M $71M
 
Common Stock -- -- $2M $2M $2M
Other Common Equity Adj -- -- -$1.8M $780.9K $1.8M
Common Equity -- -- -$32.7M -$30M -$32M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -$30.7M -$28M -$30M
 
Total Liabilities and Equity -- -- $19.2M $29.1M $41M
Cash and Short Terms -- -- $4.8M $8.3M $15.7M
Total Debt -- -- $1.8M $4.1M $18.1M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Cash and Equivalents -- -- -- $7.3M $24.3M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $10.4M $4.7M
Inventory -- -- -- $3.9M $7.5M
Prepaid Expenses -- -- -- $539.3K --
Other Current Assets -- -- -- $304.6K $3.3M
Total Current Assets -- -- -- $25.9M $41.2M
 
Property Plant And Equipment -- -- -- $1.1M $2.7M
Long-Term Investments -- -- -- $103.8K $105.2K
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $27.2M $44M
 
Accounts Payable -- -- -- $5.1M $5.7M
Accrued Expenses -- -- -- $2.5M $4.8M
Current Portion Of Long-Term Debt -- -- -- -- $8.9M
Current Portion Of Capital Lease Obligations -- -- -- $263.1K $618.8K
Other Current Liabilities -- -- -- $814.1K $518.3K
Total Current Liabilities -- -- -- $14.3M $23.3M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $53.1M $75M
 
Common Stock -- -- -- $2M $2M
Other Common Equity Adj -- -- -- $1.7M $1.9M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -$25.9M -$31M
 
Total Liabilities and Equity -- -- -- $27.2M $44M
Cash and Short Terms -- -- -- $7.3M $24.3M
Total Debt -- -- -- $4.5M $8.9M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -$2.1M $1.6M -$8.1M
Depreciation & Amoritzation -- -- $217.3K $138.1K $202.9K
Stock-Based Compensation -- -- -- -- $7.5M
Change in Accounts Receivable -- -- -$4.4M -$3.9M -$5.5M
Change in Inventories -- -- -$2.2M -$3.4M -$663.5K
Cash From Operations -- -- -$6.5M $848.7K -$5.6M
 
Capital Expenditures -- -- $93K $213.7K $525.9K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -$4.8M $1.2M $2.3M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- $3.1M $6.4M $17.4M
Long-Term Debt Repaid -- -- -$3.7M -$3.8M -$4.6M
Repurchase of Common Stock -- -- -$181.2K -- --
Other Financing Activities -- -- -$120.3K -$364.7K -$2M
Cash From Financing -- -- $15.2M $2.3M $10.7M
 
Beginning Cash (CF) -- -- $812.9K $4.8M $8.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- $3.9M $4.3M $7.4M
Ending Cash (CF) -- -- $4.8M $8.7M $15.7M
 
Levered Free Cash Flow -- -- -$6.6M $635K -$6.1M
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$2.9M -$4M
 
Capital Expenditures -- -- -- $362.4K $7.9K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- $2.5M -$115.6K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $2.2M $2.9M
Long-Term Debt Repaid -- -- -- -$1.5M -$1.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$170K $178.3K
Cash From Financing -- -- -- $522.1K $1.3M
 
Beginning Cash (CF) -- -- -- $8.7M $15.7M
Foreign Exchange Rate Adjustment -- -- -- $128.8K -$42.8K
Additions / Reductions -- -- -- $156.6K -$2.8M
Ending Cash (CF) -- -- -- $9M $12.8M
 
Levered Free Cash Flow -- -- -- -$3.3M -$4M
Period Ending 2020-06-30 2021-06-30 2022-06-30 2023-06-30 2024-06-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- $213.7K $320.2K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2020-03-31 2021-03-31 2022-03-31 2023-03-31 2024-03-31
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -$2.9M -$4M
 
Capital Expenditures -- -- -- $362.4K $7.9K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- $2.5M -$115.6K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $2.2M $2.9M
Long-Term Debt Repaid -- -- -- -$1.5M -$1.7M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$170K $178.3K
Cash From Financing -- -- -- $522.1K $1.3M
 
Beginning Cash (CF) -- -- -- $8.7M $15.7M
Foreign Exchange Rate Adjustment -- -- -- $128.8K -$42.8K
Additions / Reductions -- -- -- $156.6K -$2.8M
Ending Cash (CF) -- -- -- $9M $12.8M
 
Levered Free Cash Flow -- -- -- -$3.3M -$4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 23

Quantum [QMCO] is up 3.25% over the past day.

Sell
46
NUKK alert for Dec 23

Nukkleus [NUKK] is up 6.6% over the past day.

Sell
1
IIPR alert for Dec 23

Innovative Industrial Properties [IIPR] is down 5.78% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock